The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2014The Microbiome in Parkinson's Disease: Role as a Potential Biomarker and Relation to Disease Progression
Promising Outcomes of Original Grant:
In their previous study these researchers investigated whether the abundance of different microbes in the gut differs between Parkinson’s disease (PD) patients and... -
Rapid Response Innovation Awards, 2014Parc (a Parkin-related E3 Ligase): Functions in Neuronal Survival and Parkinson’s Disease
Objective/Rationale:
Parkinson’s disease (PD) is frequently associated with mutations in the gene that encodes Parkin, a protein that detects and degrades dysfunctional mitochondria. While removing... -
Research Grant, 2014Anti-dyskinetic Activity of the Selective 5-HT1A Agonist NLX-112: Behavioral and Microdialysis Studies
Promising Outcomes of Original Grant:
These researchers are investigating the activity of novel drugs that potently activate serotonin 5-HT1A receptors. Targeting this receptor subtype is an attractive... -
Access to Data and Biospecimens, 2014Effect of LRRK2 Mutations on PD-associated Inflammation
Objective/Rationale:
Increased inflammation is associated with the progression and possibly even onset of Parkinson’s disease (PD). Mutations in the LRRK2 gene are also associated with PD, and recent... -
Access to Data and Biospecimens, 2014Defining Non-motor Phenotypes in Parkinson’s Disease and Novel Strategies for Diagnosis
Objective/Rationale:
Although Parkinson’s disease (PD) is diagnosed as a movement disorder, motor deficits are preceded by non-motor features including cognitive, cardiovascular, gastrointestinal... -
LRRK2 Role in Idiopathic Parkinson's Disease, 2014Age-related Alterations in LRRK2 Expression and Function in Immune Cells and Risk for Idiopathic Parkinson's Disease
Objective/Rationale:
The LRRK2 protein is highly expressed in immune cells, but its function is unknown and may change as the immune system changes with aging and environmental exposures, the largest...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.